Schedule 13G ownership disclosure
NOVELION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 67001K202
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,694,717
- Percent of class
- 9.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-18-000117
- Form type
- SC 13G
- Filer
- NOVELION THERAPEUTICS INC.
- CIK
- CIK 827809
- Filed
- Feb 13, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership